Semi-Annual Statement Of Cash Flows

StemCell Institute - Filing #7253194

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
605,375,000 JPY
442,264,000 JPY
Interest and dividends received
8,854,000 JPY
3,022,000 JPY
Interest paid
-1,569,000 JPY
JPY
Income taxes paid
-144,974,000 JPY
-110,661,000 JPY
Net cash provided by (used in) operating activities
467,685,000 JPY
334,625,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-477,795,000 JPY
-183,457,000 JPY
Purchase of investment securities
-330,002,000 JPY
-199,900,000 JPY
Proceeds from sale of investment securities
186,939,000 JPY
72,327,000 JPY
Other, net
796,000 JPY
24,238,000 JPY
Net cash provided by (used in) investing activities
-259,084,000 JPY
-811,773,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
510,000,000 JPY
JPY
Repayments of long-term borrowings
-10,083,000 JPY
JPY
Purchase of treasury shares
-94,038,000 JPY
JPY
Dividends paid
-255,832,000 JPY
JPY
Net cash provided by (used in) financing activities
146,704,000 JPY
-1,333,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
355,305,000 JPY
-478,480,000 JPY
Cash and cash equivalents
3,200,846,000 JPY
2,845,540,000 JPY
3,324,021,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.